ChemicalBook >> CAS DataBase List >>LY2228820

LY2228820

CAS No.
862507-23-1
Chemical Name:
LY2228820
Synonyms
CS-371;LY2228820;LY2228820 2MsOH;Ralimetinib 2MsOH;LY2228820 USP/EP/BP;LY2228820 diMesylate;LY2228820 (mesylate);Ralimetinib Mesylate;LY2228820(LY-2228820);LY2228820 (Ralimetinib)
CBNumber:
CB82518277
Molecular Formula:
C26H37FN6O6S2
Molecular Weight:
612.7369832
MDL Number:
MFCD22572532
MOL File:
862507-23-1.mol
MSDS File:
SDS
Last updated:2023-05-21 10:59:17

LY2228820 Properties

storage temp. Store at -20°C
solubility ≥30.65 mg/mL in DMSO; ≥45 mg/mL in H2O with ultrasonic; ≥9.9 mg/mL in EtOH with ultrasonic
form solid
FDA UNII QUW7B71FO9

SAFETY

Risk and Safety Statements

HS Code  2933998090

LY2228820 price More Price(30)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 23259 LY2228820 (mesylate) ≥98% 862507-23-1 1mg $32 2024-03-01 Buy
Cayman Chemical 23259 LY2228820 (mesylate) ≥98% 862507-23-1 5mg $145 2024-03-01 Buy
Cayman Chemical 23259 LY2228820 (mesylate) ≥98% 862507-23-1 10mg $275 2024-03-01 Buy
Cayman Chemical 23259 LY2228820 (mesylate) ≥98% 862507-23-1 25mg $571 2024-03-01 Buy
TRC L486500 LY2228820 862507-23-1 50mg $1470 2021-12-16 Buy
Product number Packaging Price Buy
23259 1mg $32 Buy
23259 5mg $145 Buy
23259 10mg $275 Buy
23259 25mg $571 Buy
L486500 50mg $1470 Buy

LY2228820 Chemical Properties,Uses,Production

Uses

LY2228820 is a novel and potent p38MAPK inhibitor with potent antiinflammatory activity. LY2228820 significantly inhibited phosphorylation of MAPKAPK2 and/or HSP27, down stream targets of p38MAPK, in both multiple myeloma (MM) cell lines and LT-BMSCs. LY2228820 is a potential candidate to improve MM patient outcome both by enhancing the effect of Bortezomib (B675700) and by reducing osteoskeletal events.

Biological Activity

ly2228820 is a potent, selective, atp-competitive small-molecule inhibitor inhibiting α- and β-isoforms of p38 mapk with ic(50) values of 5.3nm and 3.2 nm, respectively1.in multiple myeloma (mm) cell lines, ly2228820 enhanced the cytotoxicity of bortezomiba via reducing bortezomib-induced phosphorylation of heat shock protein 27 (hsp27). ly2228820 significantly reduced il-6 secretion from bm mononuclear cells (bmmncs) and long term cultured-bm stromal cells (lt-bmscs). besides, ly2228820 can also inhibit secretion of macrophage inflammatory protein-1a (mip-1a) in bmmncs, cd138+ patient mm cells and normal cd14+ osteoclast cells 2.studies in mice implanted with b16-f10 melanoma showed that orally administered ly2228820 can effectively suppress the tumor-phospho-mk2 expression. treatment of ly2228820 caused a significant tumor growth delay in a549 nsclc xenograft models1.

target

p38α

References

1. campbell rm1, anderson bd, brooks na, brooks hb, chan em, de dios a, gilmour r, graff jr, jambrina e, mader m, mccann d, na s, parsons sh, pratt se, shih c, stancato lf, starling jj, tate c, velasco ja, wang y, ye xs.characterization of ly2228820 dimesylate, a potent and selective inhibitor of p38 mapk with antitumor activity. mol cancer ther. 2014 feb;13(2):364-74.2. ishitsuka k1, hideshima t, neri p, vallet s, shiraishi n, okawa y, shen z, raje n, kiziltepe t, ocio em, chauhan d, tassone p, munshi n, campbell rm, dios ad, shih c, starling jj, tamura k, anderson kc. p38 mitogen-activated protein kinase inhibitor ly2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications. br j haematol. 2008 may;141(5):598-606.

LY2228820 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 108)Suppliers
Supplier Tel Email Country ProdList Advantage
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806 sales@capotchem.com China 29797 60
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32686 60
Hubei xin bonus chemical co. LTD
86-13657291602 linda@hubeijusheng.com CHINA 22968 58
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19553 58
career henan chemical co
+86-0371-86658258 15093356674; factory@coreychem.com China 29826 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 28200 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10523 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6393 58
TargetMol Chemicals Inc.
+1-781-999-5354 support@targetmol.com United States 19973 58
LEAPCHEM CO., LTD.
+86-852-30606658 market18@leapchem.com China 43348 58

View Lastest Price from LY2228820 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
LY2228820 pictures 2020-01-13 LY2228820
862507-23-1
US $1.00 / g 1g 99% 200kg Career Henan Chemical Co
  • LY2228820 pictures
  • LY2228820
    862507-23-1
  • US $1.00 / g
  • 99%
  • Career Henan Chemical Co

LY2228820 Spectrum

5-(2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate 5-(2-(tert-butyl)-5-(4-fluorophenyl)-1H-imidazol-4-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate LY2228820;LY 2228820;LY-2228820 5-(2-tert-Butyl-5-(4-fluorophenyl)-1H-imidazol-4-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-am LY2228820 5-[2-(1,1-DiMethylethyl)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate LY2228820(LY-2228820) LY2228820 2MsOH LY2228820 diMesylate 5-[2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-3H-imidazo[4,5-b]pyridin-2-amine methanesulfonate LY2228820 (Ralimetinib) dimesylate LY2228820 (mesylate) Ralimetinib Mesylate RALIMETINIB DIMESYLATE (LY2228820 DIMESYLATE) Ralimetinib 2MsOH(LY2228820) CS-371 LY2228820 (Ralimetinib) RALIMETINIB DIMESYLATE; LY2228820 DIMESYLATE; LY2228820 2MSOH; LY 2228820; LY-2228820 Ralimetinib 2MsOH LY2228820 USP/EP/BP Ralimetinib dimysylate (LY2228820 dimysylate) Ralimetinib mesylate LY2228820 LY-2228820 862507-23-1 C24H29FN62CH4O3S C25H33FN6O3S C26H37FN6O6S2 Inhibitors Aromatics Heterocycles Intermediates & Fine Chemicals Pharmaceuticals Protein Kinase Inhibitors and Activators MAPK